Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection | Zendy

Andrew W. Woodham | Zendy; Julia R. Taylor | Zendy; Andrew I. Jimenez | Zendy; Joseph G. Skeate | Zendy; Thomas Schmidt | Zendy; Heike E. Brand | Zendy; Diane M. Da Silva | Zendy; W. Martin Kast | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection

Author(s) -

Andrew W. Woodham,

Julia R. Taylor,

Andrew I. Jimenez,

Joseph G. Skeate,

Thomas Schmidt,

Heike E. Brand,

Diane M. Da Silva,

W. Martin Kast

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv045

Subject(s) - heterotetramer , annexin a2 , biology , cytotoxicity , trypan blue , hela , annexin , microbiology and biotechnology , flow cytometry , in vitro , immunology , biochemistry , protein subunit , gene

High-risk human papillomavirus (HPV) infection leads to the development of several human cancers that cause significant morbidity and mortality worldwide. HPV type 16 (HPV16) is the most common of the cancer-causing genotypes and gains entry to the basal cells of the epithelium through a non-canonical endocytic pathway that involves the annexin A2/S100A10 heterotetramer (A2t). A2t is composed of two annexin A2 monomers bound to an S100A10 dimer and this interaction is a potential target to block HPV16 infection. Here, recently identified small molecule inhibitors of A2t (A2ti) were investigated for their ability to prevent HPV16 infection in vitro.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research